Table 1.
| DSA | No DSA | p-value | |
|---|---|---|---|
| n | 69 | 152 | |
|
| |||
| Age (y) | 53.8 (42.5–62.8) | 59.4 (47.0–64.3) | 0.17 |
|
| |||
| Sex | 0.08 | ||
| Male (%) | 47 (68.1) | 120 (79.0) | |
| Female (%) | 22 (31.9) | 32 (21.0) | |
|
| |||
| Donor Age (y) | 46 (33.0–60.0) | 50.5 (34.5–61.0) | 0.21 |
|
| |||
| MCS Bridge (%) | 33 (43.8) | 95 (62.5) | 0.04 |
|
| |||
| Induction (%) | 51 (73.9) | 102 (67.1) | 0.31 |
|
| |||
| AMR (%) n=210 | 27 (39.1) | 11 (7.8) | <0.0001 |
|
| |||
| ACR (%) n=210 | 41 (59.4) | 35 (24.8) | <0.001 |
|
| |||
| Sensitized Pretransplant (%) | 11 (15.9) | 7 (4.6) | 0.004 |
|
| |||
| MHC Class of DSA | |||
| Class I Only | 14 (20.3) | ||
| Class II Only | 34 (49.3) | ||
| Class I & II | 21 (30.4) | ||
MCS=Mechanical circulatory support; AMR=Antibody mediated rejection; ACR= Acute cellular rejection; DSA=Donor specific antibodies